ISPE is led by an International Board of Directors. Jörg Zimmermann is the Society’s Chair for 2021 – 2022.
Officers
Jörg Zimmermann
- Chair | Vice President, Vetter Development Service, External Affairs
- Vetter Pharma-Fertigung GmbH & Co.
Scott W. Billman
- Treasurer
- Global Head of Engineering
Jeffrey A. Biskup, PE
- Secretary | CEO and Chairman of the Board
- CRB
Joanne R. Barrick, RPh
- Past Chair | Advisor, Global Validation
- Eli Lilly and Company
Thomas B. Hartman
- Ex Officio Non-voting Member | President and CEO
- ISPE
Directors
Vivianne J. Arencibia
- Independent Consultant
- Arencibia Quality Compliance Associates
Nina S. Cauchon, PhD
- Director Regulatory Affairs - CMC
- Amgen Inc.
Michael L. Rutherford
- Vice Chair | Executive Director, Computer Systems Quality & Data Integrity
- Syneos Health
Chris Chen, PhD
- CEO
- WuXi Biologics (Shanghai) Co., Ltd.
David Doleski
- Compliance Head for Biologics Quality Operations
- Sanofi
Teresa Minero
- Founder & CEO
- LifeBee - Digitalizing Life Sciences
Hirofumi Suzuki, PhD
- Product Supply Japan, Head of Product Supply Coordination
- Bayer Yakuhin Ltd
Ylva Ek
- Chief Quality Officer (CQO)
- KeyPlants AB
Lou W. Kennedy
- CEO and Owner | Nephron Pharmaceuticals
- New Directors
Georg Singewald, PhD
- VP, Head of Global Quality Control
- Genentech, A Member of the Roche Group
Timothy J.N. Watson, PhD
- Executive Director & Team Leader, CMC Advisory Office
- Pfizer Inc
- Board Members Continuing a Term in 2021-2022